Effects of Ticagrelor versus Clopidogrel in Patients with Coronary Bifurcation Lesions Undergoing Percutaneous Coronary Intervention

Table 3

Clinical outcomes during 1-year follow-up in the overall population.

Overall population	Clopidogrel; (n=283)	Ticagrelor; (n=270)	Adjusted HR; (95%CI)	P value
Primary end point
Cardiac death, MI, or Stroke	34(12.01)	22(8.15)	0.488(0.277-0.861)	0.013
Secondary end point
Cardiac death	6(2.12)	5(1.85)	0.540(0.146-1.999)	0.356
MI	24(8.48)	12(4.44)	0.341(0.162-0.719)	0.005
Stroke	6(2.12)	6(2.22)	0.717(0.204-2.512)	0.603
Stent thrombosis	9(3.18)	5(1.85)	0.415(0.131-1.319)	0.136
Bleeding
All BARC type Bleeding	43(15.19)	68(25.19)	1.791(1.214-2.644)	0.003
Major bleeding	7(2.47)	8(2.96)	0.972(0.321-2.941)	0.960

Results are expressed as n (%).
MI: myocardial infarction; BARC: Bleeding Academic Research Consortium.